Hemobag® Whole Blood Recovery System
The Hemobag® is an FDA-cleared autotransfusion system that recovers concentrated whole blood during cardiac surgery. Unlike standard cell salvage methods that discard platelets, clotting factors, and plasma proteins, the Hemobag® preserves all blood components for re-infusion to the patient.
Trusted by perfusionists, surgeons, and hospital administrators worldwide, the Hemobag® reduces transfusion requirements, lowers bleeding risk, and improves patient outcomes—all while reducing healthcare costs.
Key Benefits of the Hemobag®
Complete Blood Component Recovery
Recovers red cells, platelets, clotting factors, and plasma proteins—all preserved and returned to the patient.
Reduced Transfusion Requirements
Less dependence on donor blood means lower costs and reduced complication risks.
Fast and Easy to Use
The full process from collection to reinfusion takes only 8-10 minutes.
Clinically Proven Results
Clinically proven to improve patient outcomes in cardiac surgery while providing a cost-effective blood conservation solution for hospitals.
Explore Our Resources
- Learn about the Hemobag® methodology and clinical evidence
- Clinical information for perfusionists and cardiac surgeons
- Request product information or place an order
Why Choose Whole Blood Recovery?
Advanced Ultrafiltration Technology
Traditional cell salvage devices wash and discard valuable blood components. The Hemobag® uses ultrafiltration technology to concentrate residual cardiopulmonary bypass blood, returning a hemoconcentrated product that includes platelets, fibrinogen, and other clotting factors essential for hemostasis.